Cullinan Therapeutics, Inc. - Common Stock (CGEM)
CUSIP: 230031106
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,091,689
- Total 13F shares
- 33,862,280
- Share change
- +1,619,544
- Total reported value
- $762,265,836
- Price per share
- $22.57
- Number of holders
- 63
- Value change
- +$33,803,888
- Number of buys
- 39
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 230031106?
CUSIP 230031106 identifies CGEM - Cullinan Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230031106:
Top shareholders of CGEM - Cullinan Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC |
13F
|
Company |
13%
|
7,913,887
|
$203,783,000 | — | 30 Jun 2021 | |
| UBS Oncology Impact Fund L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
7,648,268
|
$95,297,419 | — | 16 Sep 2021 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
4.6%
|
2,731,410
|
$70,334,000 | — | 30 Jun 2021 | |
| CHI Advisors LLC |
13F
|
Company |
3.8%
|
2,242,841
|
$57,753,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
3.3%
|
1,977,907
|
$50,931,000 | — | 30 Jun 2021 | |
| BAUPOST GROUP LLC/MA |
13F
|
Company |
3.1%
|
1,835,560
|
$46,277,000 | — | 30 Jun 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,440,145
|
$36,155,000 | — | 30 Jun 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
2.1%
|
1,231,121
|
$31,702,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
1,155,765
|
$29,761,000 | — | 30 Jun 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.9%
|
1,146,145
|
$29,513,000 | — | 30 Jun 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.8%
|
1,075,912
|
$27,705,000 | — | 30 Jun 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.8%
|
1,074,082
|
$27,658,000 | — | 30 Jun 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.8%
|
1,044,000
|
$26,883,000 | — | 30 Jun 2021 | |
| VR Adviser, LLC |
13F
|
Company |
1.7%
|
976,145
|
$25,136,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.6%
|
942,278
|
$24,264,000 | — | 30 Jun 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.3%
|
777,498
|
$20,021,000 | — | 30 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
1.2%
|
735,106
|
$18,929,000 | — | 30 Jun 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.95%
|
561,206
|
$14,451,000 | — | 30 Jun 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.59%
|
350,000
|
$9,013,000 | — | 30 Jun 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.5%
|
295,596
|
$7,613,000 | — | 30 Jun 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.49%
|
288,458
|
$7,428,000 | — | 30 Jun 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.41%
|
240,798
|
$6,201,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
233,661
|
$6,017,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.39%
|
232,922
|
$5,997,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.39%
|
227,843
|
$5,867,000 | — | 30 Jun 2021 | |
| Eversept Partners, LP |
13F
|
Company |
0.28%
|
163,880
|
$4,219,910 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
132,374
|
$3,409,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
123,370
|
$3,177,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.17%
|
103,108
|
$2,655,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.17%
|
100,000
|
$2,575,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
89,699
|
$2,310,000 | — | 30 Jun 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.13%
|
78,000
|
$2,009,000 | — | 30 Jun 2021 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
75,732
|
$1,950,000 | — | 30 Jun 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.13%
|
74,951
|
$1,930,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
66,348
|
$1,709,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.1%
|
60,319
|
$1,553,000 | — | 30 Jun 2021 | |
| Birchview Capital, LP |
13F
|
Company |
0.08%
|
45,114
|
$1,162,000 | — | 30 Jun 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.08%
|
45,000
|
$1,159,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
39,627
|
$1,020,000 | — | 30 Jun 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
39,113
|
$1,007,000 | — | 30 Jun 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.06%
|
32,520
|
$837,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
28,600
|
$736,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
25,982
|
$669,000 | — | 30 Jun 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
18,248
|
$470,000 | — | 30 Jun 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.03%
|
15,072
|
$388,000 | — | 30 Jun 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
15,027
|
$387,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
14,636
|
$376,000 | — | 30 Jun 2021 | |
| DARK FOREST CAPITAL MANAGEMENT LP |
13F
|
Company |
0.02%
|
14,172
|
$365,000 | — | 30 Jun 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
13,800
|
$355,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
12,353
|
$318,000 | — | 30 Jun 2021 |
Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock (CGEM) as of Q3 2021
As of 30 Sep 2021,
Cullinan Therapeutics, Inc. - Common Stock (CGEM) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,862,280 shares.
The largest 10 holders included
BioImpact Capital LLC, Foresite Capital Management V, LLC, FMR LLC, VANGUARD GROUP INC, CHI Advisors LLC, BAUPOST GROUP LLC/MA, BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, AMERICAN INTERNATIONAL GROUP, INC., and ORBIMED ADVISORS LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
70
Q3 2021 holders
63
Holder diff
-7
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.